Kudzu
11 benefits mapped to clinical evidence across supplements.
Dose per serving from research
7 study groups in 6 studies say how much Kudzu participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 29% of 7 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg or less | 1 |
| 100 mg to 250 mg | 1 |
| 250 mg to 500 mg | 1 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 2 |
| 2.5 g to 5 g | 1 |
Commonly used together
3 of 7 study groups took Kudzu with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Riboflavin (vitamin B2) | 3 |
Benefit Evidence
Menopause relief; FSH/LH stable
Vaginal estrogenic effects; VMI +172%
Endothelial function, IMT
Blood pressure, fibrinolysis
Vaginal flow, PI -56%
Endothelial function, IMT
Blood pressure, fibrinolysis
Vaginal flow, PI -56%
Research sources
Hormone balance (8)
- Efficacy and Safety of Kudzu Flower-Mandarin Peel on Hot Flashes and Bone Markers in Women during the Menopausal Transition: A Randomized Controlled Trial
PubMed ID: 33105861
Kudzu flower + mandarin peel reduced hot-flash frequency/severity in peri/postmenopausal women.
- Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study
PubMed ID: 14971532
Pueraria mirifica reduced menopausal symptom scores over 6 months in a small open-label study.
- Effect of Pueraria mirifica on vaginal health
PubMed ID: 17415017
Randomized double-blind trial: Pueraria mirifica improved vaginal cell maturation and reduced vaginal dryness.
- Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study
PubMed ID: 17957910
Randomized phase III trial: Pueraria mirifica relieved menopausal symptoms comparably to standard estrogen therapy.
- Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms
PubMed ID: 20872225
Dose-comparison trial found both 25 mg and 50 mg Pueraria mirifica reduced menopausal symptom scores.
- Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women
PubMed ID: 27749740
Vaginal Pueraria mirifica gel improved vaginal maturation and symptoms versus baseline (CEE more potent).
- Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM)
PubMed ID: 32972635
Vaginal Pueraria mirifica gel improved Nugent scores and vaginal health index, relevant to genitourinary menopausal changes.
- Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause
PubMed ID: 35550707
Topical Pueraria mirifica (a Pueraria species related to kudzu) improved vaginal maturation index and vascular indices, consistent with estrogenic relief of menopausal vaginal atrophy.
Blood circulation (7)
- The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients
PubMed ID: 19388864
Salvia miltiorrhiza + Pueraria lobata improved flow-mediated dilation and reduced carotid IMT in coronary patients.
- A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia
PubMed ID: 24906587
Danshen+Gegen modestly reduced carotid IMT and lowered LDL/TC in postmenopausal women, suggesting vascular benefit.
- Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function
PubMed ID: 37782173
Gelanxinning (includes Pueraria) improved endothelial and microvascular biomarkers (endocan) in coronary patients.
- [Clinical study on Tianbaokang injection against oxidative injury of vascular endothelial function in ischemic apoplexy]
PubMed ID: 12795227
Multi-herb injection improved NO levels and other endothelial/oxidative markers in stroke patients.
- [Effect of ningxintong granule in treating patients of coronary heart disease with left ventricular diastolic dysfunction and qi-deficiency blood-stasis syndrome]
PubMed ID: 20669668
Combined herbal granule (includes pueraria) improved left ventricular diastolic function parameters.
- Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension
PubMed ID: 24171260
Pueraria tuberosa improved hemodynamic measures (large BP lowering) and fibrinolysis, indicating improved vascular function.
- Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause
PubMed ID: 35550707
Study showed increased vaginal blood flow and reductions in pulsatility and resistance indices, indicating improved local circulation.
Antioxidant (3)
- Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function
PubMed ID: 37782173
Gelanxinning (includes Pueraria) reduced inflammatory biomarkers linked to oxidative stress.
- Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension
PubMed ID: 24171260
Reported increases in antioxidant status in hypertensive patients after Pueraria tuberosa.
- [Clinical study on Tianbaokang injection against oxidative injury of vascular endothelial function in ischemic apoplexy]
PubMed ID: 12795227
Multi-herb injection including Pueraria increased SOD and decreased MDA (oxidative markers) in stroke patients.
Inflammation (2)
- Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function
PubMed ID: 37782173
Gelanxinning (with Pueraria) significantly lowered NLRP3 and IL-1 and improved inflammatory biomarkers in coronary patients.
- Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial
PubMed ID: 38879879
24-week multi-herb tablet including puerarin significantly reduced hs-CRP in NAFLD patients.
Bone health (2)
- Efficacy and Safety of Kudzu Flower-Mandarin Peel on Hot Flashes and Bone Markers in Women during the Menopausal Transition: A Randomized Controlled Trial
PubMed ID: 33105861
Kudzu flower + mandarin peel improved bone turnover markers (reduced CTx) in peri/postmenopausal women.
- Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women
PubMed ID: 18202589
Pueraria mirifica produced estrogen-like changes in bone turnover markers without endometrial stimulation.
Mental clarity (1)
- Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause
PubMed ID: 12851519
Pueraria lobata produced modest improvements in some cognitive tests in postmenopausal women.
Detoxification (1)
- Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial
PubMed ID: 38879879
Increased ALDH activity in NAFLD patients suggests enhanced aldehyde metabolism/detoxification potential.
Liver support (1)
- Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial
PubMed ID: 38879879
Herbal tablet including puerarin increased ALDH activity and showed a trend toward reduced liver fat in NAFLD patients.
Blood sugar (1)
- Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans
PubMed ID: 22878195
Kudzu flower extract reduced visceral fat and BMI in obese adults, a favorable metabolic effect relevant to glucose regulation.
Wellbeing (1)
- Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans
PubMed ID: 22878195
Kudzu flower extract reduced BMI and visceral fat in obese adults, representing a meaningful wellness/metabolic benefit.
Blood pressure (1)
- Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension
PubMed ID: 24171260
Pueraria tuberosa markedly lowered systolic (~25 mmHg) and diastolic (~11 mmHg) BP in stage 1 hypertensives.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Kudzu
Search all88 products whose verified label declares Kudzu — not every bottle that mentions it in a title.